Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2025 04:56 ET | Source: Research and Markets

Analysis of Cancer Immunotherapy Technologies and Global Markets to 2029 - Merck, Roche, Bristol-Myers Squibb Company, Johnson & Johnson Services, and AstraZeneca Dominate

Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The global cancer immunotherapy...
February 18, 2025 09:06 ET | Source: Research and Markets

Oncolytic Virus Cancer Therapy Pipeline Market Report: Competitive Analysis of Oncostar, Astellas, and Johnson & Johnson, T-VEC, Pelareorep, and VSV Lead Innovations

Dublin, Feb. 18, 2025 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Cancer Therapy Pipeline Analysis Report" report has been added to ResearchAndMarkets.com's offering.The oncolytic virus cancer therapy...
December 04, 2024 10:55 ET | Source: Research and Markets

Cancer Immunotherapy Strategic Research Business Report 2023-2030: Improved Delivery Systems, Desire for Non-Toxic Treatments, Checkpoint Inhibitors Spur New Developments and Growth

Dublin, Dec. 04, 2024 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cancer...
November 22, 2024 08:25 ET | Source: Research and Markets

Cancer Gene Therapy Strategic Business Report 2024: Global Market to Grow by $6.5 Billion by 2030 - Rising Interest in Oncolytic Virus Therapy Generates New Opportunities

Dublin, Nov. 22, 2024 (GLOBE NEWSWIRE) -- The "Cancer Gene Therapy - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cancer Gene...
September 05, 2024 04:33 ET | Source: Research and Markets

Global Oncolytic Virus Immunotherapy Market 2024-2030: IMLYGIC, Oncorine, Delytact Availability, Dosage, Price Analysis,Opportunity & Clinical Trials Insights

Dublin, Sept. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Immunotherapy Market Opportunity & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's...
August 22, 2024 04:04 ET | Source: Research and Markets

Oncolytic Virus Therapy Research Report 2024-2030: Market Poised for Expansion Across Multiple Cancer Types, Including Melanoma and Ovarian Cancer

Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Oncolytic Virus Therapy Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
July 11, 2024 07:19 ET | Source: KuicK Research

Global Oncolytic Immunotherapy Clinical Trials Market Forecast Companies FDA approval Insight

Delhi, July 11, 2024 (GLOBE NEWSWIRE) -- Global Oncolytic Virus Immunotherapy Market Opportunity and Clinical Trials Insight 2030 Report Highlights: Global Oncolytic Virus Immunotherapy Therapy...
June 27, 2024 06:03 ET | Source: Research and Markets

Global Oncolytic Virus Therapy Industry Research 2024-2032: Strategic Collaborations to Increase Market Share, Oncolytic Wild-type Viruses Driving Therapeutic Innovation, North America Leads

Dublin, June 27, 2024 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Therapy Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
June 25, 2024 12:27 ET | Source: Research and Markets

Oncology Drugs Market Projected to Surge to $340 Billion by 2031 - Insights Into the Products, Technologies, Grades, Applications, End-users, and Regions

Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Oncology Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application,...
May 14, 2024 08:50 ET | Source: Research and Markets

Global Oncolytic Virus Immunotherapy Market & Clinical Trials Insight - A USD 1.50 Billion+ Market Opportunity by 2030

Dublin, May 14, 2024 (GLOBE NEWSWIRE) -- The "Global Oncolytic Virus Immunotherapy Market Opportunity & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering....

Next Page keyboard_arrow_right